Arbutus Biopharma

In News

Arbutus Biopharma shares jump after unveiling $230 million share buyback plan - Yahoo Finance

Yahoo Finance - Aug 21, 2026

Is Arbutus Biopharma (ABUS) Fully Valued Following Its $230 Million Tender Offer? - Simply Wall Street

Simply Wall Street - Aug 26, 2026

ABUS Stock Price, Quote & Chart - ChartMill

ChartMill - Oct 09, 2026

10 Health Care Stocks With Whale Alerts In Today’s Session - Arbutus Biopharma (NASDAQ:ABUS), Novo Nordis - Benzinga

Benzinga - Sep 25, 2026

Morgan Stanley reports owning more than 10% of Arbutus Biopharma (ABUS) in an amendment. - Stock Titan

Stock Titan - Oct 07, 2026

Arbutus Biopharma: Moderna Validates My IP Bull Case (NASDAQ:ABUS) - Seeking Alpha

Seeking Alpha - Jul 13, 2026

Arbutus Biopharma Announces Preliminary Results of US$230 Million Substantial Issuer Bid Tender Offer - Quiver Quantitative

Quiver Quantitative - Sep 30, 2026

ABUS Stock Surges 10% Today — What’s Driving This Super Rally? - TradingView

TradingView - Aug 21, 2026

Arbutus Announces Intent to Repurchase Up to US$230 Million - GlobeNewswire

GlobeNewswire - Aug 21, 2026

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage? - Yahoo Finance

Yahoo Finance - Aug 10, 2026

At $5 a share, Arbutus Biopharma (ABUS) accepts tendered shares; Roivant retains about 19.5%. - Stock Titan

Stock Titan - Oct 05, 2026

Arbutus Biopharma (ABUS) Joins Russell Defensive Indexes And Exits Value Benchmarks - Yahoo Finance

Yahoo Finance - Jul 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment